AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

AngioDynamics (ANGO) Tops Q2 EPS by 10c, Beats on Revenue; Offers Guidance

January 6, 2026 6:05 AM EST

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.00, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.4 million versus the consensus estimate of $76.3 million.

GUIDANCE:

AngioDynamics sees FY2026 EPS of ($0.33)-($0.23), versus the consensus of ($0.33). AngioDynamics sees... More